BiomeSense, Inc. — Form D
BiomeSense, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-03. The offering totals $7.3M, of which $7.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-11-03
- Form: D
- Accession: 0001789915-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.3M
- Amount sold: $7.1M
- Remaining: $190K
- Investors: 27
- Date of first sale: 2025-07-18
- Revenue range: Decline to Disclose
- SEC file number: 021-562823
Issuer
- Name: BiomeSense, Inc.
- CIK: 0001789915
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 2242 W. HARRISON ST, CHICAGO, IL, 60612
- Phone: 847-471-8663
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Andrew Bluestein | Director | Chicago, IL |
| Vanessa Rollings Giannis | Director | Chicago, IL |
| Ashley Hartman | Director | Chicago, IL |
| Kevin Honaker | Director | Chicago, IL |
| Dylan Nichols | Director | Chicago, IL |
| Kevin Honaker | Executive Officer | Chicago, IL |
| Parikshit Sharma | Director | Chicago, IL |
| Orhan Ertughrul | Director | Chicago, IL |
Other filings by this issuer (2)
More